Envoy Medical, Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
COCH Nasdaq 3840 www.envoymedical.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Envoy Medical, Inc.

Envoy Medical Submits First Module of Modular Premarket Approval Application to the U.S. Food and Drug Administration for Breakthrough-Designated Device - Jun 30th, 2026 6:30 am
Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing - Jun 26th, 2026 6:35 am
Envoy Medical Terminates At-the-Market (ATM) Equity Facility - Jun 25th, 2026 6:30 am
Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th - Jun 23rd, 2026 6:35 am
Envoy Medical to Present at Investor Conferences on June 25th - Jun 18th, 2026 6:30 am
Envoy Medical to Present at Planet MicroCap Conference Las Vegas on June 16th-18th - Jun 4th, 2026 6:30 am
Envoy Medical (NASDAQ:COCH) Signs Multi-Part Series With New to The Street - Jun 2nd, 2026 6:30 am
Envoy Medical Announces New Patents Expanding Intellectual Property Portfolio in Fully Implanted Hearing Technology - May 20th, 2026 6:30 am
Envoy Medical Reports Landmark Accomplishments, Advancing Toward FDA Approval of First-of-Its-Kind Fully Implanted Cochlear Implant - May 11th, 2026 6:00 am
TransMedics (TMDX) Q1 Earnings and Revenues Miss Estimates - May 5th, 2026 4:05 pm
Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant - Apr 28th, 2026 6:30 am
Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant - Apr 22nd, 2026 6:00 am
Envoy Medical Appoints Chas McKhann to Board of Directors - Apr 16th, 2026 6:00 am
Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant - Apr 1st, 2026 6:00 am
Envoy Medical Reports Full Year 2025 Financial Results - Mar 23rd, 2026 6:30 am
Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant - Mar 11th, 2026 6:00 am
Envoy Medical Regains Compliance with Nasdaq Listing Requirement - Feb 24th, 2026 6:00 am
Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space - Feb 23rd, 2026 6:00 am
Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial - Feb 19th, 2026 6:00 am
Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant - Feb 17th, 2026 6:00 am